Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2007

01-02-2007 | Article

Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia

Authors: M. L. H. Cuijpers, F. J. Vos, C. P. Bleeker-Rovers, P. F. M. Krabbe, P. Pickkers, A. P. J. van Dijk, G. J. A. Wanten, P. D. Sturm, W. J. G. Oyen, B. J. Kullberg

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2007

Login to get access

Abstract

Complicating infectious foci resulting from haematogenous or local spread of microorganisms are observed frequently in patients with Staphylococcus aureus bacteraemia (SAB) or Streptococcus species bacteraemia (SSB). The aim of this study was to compare the epidemiology of complicating infectious foci during SAB and SSB in a university hospital in The Netherlands. The charts of all adult patients diagnosed with SAB or SSB (except for Streptococcus pneumoniae bacteraemia) from July 2002 until December 2004 were reviewed retrospectively. Overall, 180 immunocompetent patients were identified, 127 with SAB and 53 with SSB. The percentage of patients with complicating infectious foci (39% of SAB patients, 25% of SSB patients) did not differ significantly between the groups. Endocarditis and cerebral involvement, however, were significantly more common in the SSB group. Of all complicating infectious foci, 32% lacked guiding signs or symptoms and 10% were detected only at autopsy. Factors associated with the development of complicating infectious foci were a delay in treatment for more than 48 h after the onset of symptoms, community acquisition, persistently positive blood cultures, congenital heart disease, and the presence of foreign bodies or prosthetic valves. Infection-related mortality was 18% in SAB patients and 11% in SSB patients and was significantly higher in patients with complicating infectious foci (29 vs. 9%). In conclusion, complicating infectious foci develop in approximately one-third of all patients with SAB and SSB. An active approach that entails searching for the complicating infectious foci is warranted in these patients, because only two-thirds of complicated infectious foci have guiding symptoms or signs, and infection-related mortality is significantly increased in patients with complicating infectious foci compared to patients without these infections.
Literature
1.
go back to reference Lautenschlager S, Herzog C, Zimmerli W (1993) Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin Infect Dis 16:567–573PubMed Lautenschlager S, Herzog C, Zimmerli W (1993) Course and outcome of bacteremia due to Staphylococcus aureus: evaluation of different clinical case definitions. Clin Infect Dis 16:567–573PubMed
3.
go back to reference Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N (2002) Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162:25–32PubMedCrossRef Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhøj P, Frimodt-Møller N (2002) Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 162:25–32PubMedCrossRef
4.
go back to reference Verhagen DW, van der Meer JT, Hamming T, de Jong MD, Speelman P (2003) Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis 35:459–463PubMedCrossRef Verhagen DW, van der Meer JT, Hamming T, de Jong MD, Speelman P (2003) Management of patients with Staphylococcus aureus bacteraemia in a university hospital: a retrospective study. Scand J Infect Dis 35:459–463PubMedCrossRef
5.
go back to reference Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR (1998) Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27:478–486PubMed Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR (1998) Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27:478–486PubMed
6.
go back to reference Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066–2072PubMedCrossRef Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, Cheng AC, Dudley T, Oddone EZ (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163:2066–2072PubMedCrossRef
7.
go back to reference Hindsholm M, Schonheyder HC (2002) Clinical presentation and outcome of bacteraemia caused by beta-haemolytic streptococci serogroup. G APMIS 110:554–558CrossRef Hindsholm M, Schonheyder HC (2002) Clinical presentation and outcome of bacteraemia caused by beta-haemolytic streptococci serogroup. G APMIS 110:554–558CrossRef
8.
go back to reference Westling K, Ljungman P, Thalme A, Julander I (2002) Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scand J Infect Dis 34:316–319PubMedCrossRef Westling K, Ljungman P, Thalme A, Julander I (2002) Streptococcus viridans septicaemia: a comparison study in patients admitted to the departments of infectious diseases and haematology in a university hospital. Scand J Infect Dis 34:316–319PubMedCrossRef
9.
go back to reference Schugk J, Harjola VP, Sivonen A, Vuopio-Varkila J, Valtonen M (1997) A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. Scand J Infect Dis 29:233–238PubMedCrossRef Schugk J, Harjola VP, Sivonen A, Vuopio-Varkila J, Valtonen M (1997) A clinical study of beta-haemolytic groups A, B, C and G streptococcal bacteremia in adults over an 8-year period. Scand J Infect Dis 29:233–238PubMedCrossRef
10.
go back to reference Bernaldo de Quiros JC, Moreno S, Cercenado E, Diaz D, Berenguer J, Miralles P, Catalan P, Bouza E (1997) Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) 76:238–248CrossRef Bernaldo de Quiros JC, Moreno S, Cercenado E, Diaz D, Berenguer J, Miralles P, Catalan P, Bouza E (1997) Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) 76:238–248CrossRef
11.
go back to reference Espersen F, Frimodt-Møller N (1986) Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 146:1118–1121PubMedCrossRef Espersen F, Frimodt-Møller N (1986) Staphylococcus aureus endocarditis. A review of 119 cases. Arch Intern Med 146:1118–1121PubMedCrossRef
12.
go back to reference Lesens O, Hansmann Y, Storck D, Christmann D (2003) Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur J Intern Med 14:227–231PubMedCrossRef Lesens O, Hansmann Y, Storck D, Christmann D (2003) Risk factors for metastatic infection in patients with Staphylococcus aureus bacteremia with and without endocarditis. Eur J Intern Med 14:227–231PubMedCrossRef
13.
go back to reference Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, Meyer P, Connel BO, Monteil H, Christmann D, Bergin C (2004) Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 48:245–252PubMedCrossRef Lesens O, Hansmann Y, Brannigan E, Remy V, Hopkins S, Martinot M, Meyer P, Connel BO, Monteil H, Christmann D, Bergin C (2004) Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 48:245–252PubMedCrossRef
14.
go back to reference Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K, Fuchs PC, Gustafson M, Wong ES, Goetz A, Wagener MM, Yu VL (1993) Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med 119:560–567PubMed Fang G, Keys TF, Gentry LO, Harris AA, Rivera N, Getz K, Fuchs PC, Gustafson M, Wong ES, Goetz A, Wagener MM, Yu VL (1993) Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective, multicenter study. Ann Intern Med 119:560–567PubMed
15.
go back to reference Murdoch DR, Roberts SA, Fowler JV Jr, Shah MA, Taylor SL, Morris AJ, Corey GR (2001) Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 32:647–649PubMedCrossRef Murdoch DR, Roberts SA, Fowler JV Jr, Shah MA, Taylor SL, Morris AJ, Corey GR (2001) Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 32:647–649PubMedCrossRef
16.
go back to reference Gopal AK, Fowler VG Jr, Shah M, Gesty-Palmer D, Marr KA, McClelland RS, Kong LK, Gottlieb GS, Lanclos K, Li J, Sexton DJ, Corey GR (2000) Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 18:1110–1115PubMed Gopal AK, Fowler VG Jr, Shah M, Gesty-Palmer D, Marr KA, McClelland RS, Kong LK, Gottlieb GS, Lanclos K, Li J, Sexton DJ, Corey GR (2000) Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 18:1110–1115PubMed
17.
go back to reference Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638PubMedCrossRef
18.
go back to reference Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14:1201–1207PubMed Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14:1201–1207PubMed
19.
go back to reference Shenep JL (2000) Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 14:129–135PubMedCrossRef Shenep JL (2000) Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 14:129–135PubMedCrossRef
20.
go back to reference Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162:90–94PubMedCrossRef Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr (2002) Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162:90–94PubMedCrossRef
21.
go back to reference Nolan CM, Beaty HN (1976) Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med 60:495–500PubMedCrossRef Nolan CM, Beaty HN (1976) Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med 60:495–500PubMedCrossRef
22.
go back to reference Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR (1999) Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 28:106–114PubMed Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J, Ryan T, Sexton DJ, Roussakis G, Harrell LJ, Corey GR (1999) Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 28:106–114PubMed
23.
go back to reference Roder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT (1999) Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 159:462–469PubMedCrossRef Roder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT (1999) Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 159:462–469PubMedCrossRef
24.
go back to reference Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T (1997) Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30:1072–1078PubMedCrossRef Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK, Kong LK, Gottlieb G, Donovan CL, Sexton DJ, Ryan T (1997) Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 30:1072–1078PubMedCrossRef
25.
go back to reference Bleeker-Rovers CP, Vos FJ, Wanten GJ, van der Meer JW, Corstens FH, Kullberg BJ, Oyen WJ (2005) 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 46:2014–2019PubMed Bleeker-Rovers CP, Vos FJ, Wanten GJ, van der Meer JW, Corstens FH, Kullberg BJ, Oyen WJ (2005) 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 46:2014–2019PubMed
26.
go back to reference Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL (2003) Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333–339CrossRef Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL (2003) Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) 82:333–339CrossRef
27.
go back to reference Fowler VG Jr, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, Gesty-Palmer D, Harrell LJ (1999) Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 179:1157–1161PubMedCrossRef Fowler VG Jr, Kong LK, Corey GR, Gottlieb GS, McClelland RS, Sexton DJ, Gesty-Palmer D, Harrell LJ (1999) Recurrent Staphylococcus aureus bacteremia: pulsed-field gel electrophoresis findings in 29 patients. J Infect Dis 179:1157–1161PubMedCrossRef
28.
go back to reference Hartstein AI, Mulligan ME, Morthland VH, Kwok RY (1992) Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 30:670–674PubMed Hartstein AI, Mulligan ME, Morthland VH, Kwok RY (1992) Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 30:670–674PubMed
Metadata
Title
Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia
Authors
M. L. H. Cuijpers
F. J. Vos
C. P. Bleeker-Rovers
P. F. M. Krabbe
P. Pickkers
A. P. J. van Dijk
G. J. A. Wanten
P. D. Sturm
W. J. G. Oyen
B. J. Kullberg
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2007
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-006-0238-4

Other articles of this Issue 2/2007

European Journal of Clinical Microbiology & Infectious Diseases 2/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.